直腸癌新輔助放化療與手術(shù)間隔時(shí)間對(duì)臨床和腫瘤學(xué)結(jié)局的影響
發(fā)布時(shí)間:2021-08-31 13:22
目的:分析延長(zhǎng)局部進(jìn)展期中、低位直腸癌放療后手術(shù)間隔時(shí)間至70天對(duì)短期臨床結(jié)局及腫瘤學(xué)結(jié)局的影響。方法:局部進(jìn)展期直腸癌患者新輔助放化療后,根據(jù)放療完成后與手術(shù)間隔時(shí)間分為短間隔組(<70天)和長(zhǎng)間隔組(≥70天),分析手術(shù)間隔時(shí)間與手術(shù)難度、術(shù)后并發(fā)癥、病理完全緩解、無(wú)疾病生存期及總生存期的關(guān)系。結(jié)果:兩組患者基本信息、新輔助放化療前腫瘤臨床特征無(wú)明顯差異。長(zhǎng)間隔組手術(shù)(285mins)時(shí)間高于短間隔組(238.5mins),有統(tǒng)計(jì)學(xué)差異。短間隔組中低位直腸癌保肛率(62.07%)高于長(zhǎng)間隔組(55.38%),并且短間隔組吻合口瘺發(fā)生率(2.78%)低于長(zhǎng)間隔組(13.89%),但均無(wú)統(tǒng)計(jì)學(xué)差異。短間隔組腫瘤降期率(68.97%)高于長(zhǎng)間期組(50.77%),有明顯統(tǒng)計(jì)學(xué)差異(P=0.04);但術(shù)后病理完全緩解率長(zhǎng)間隔組(16.92%)高于短間隔組(15.52%)。多因素分析顯示病理完全緩解與間隔時(shí)間無(wú)關(guān)。中位隨訪時(shí)間為39(6-84)月,3年無(wú)疾病進(jìn)展期在短間隔組為75.9%,長(zhǎng)間隔組為64.60%,無(wú)統(tǒng)計(jì)學(xué)意義。3年總生存期在短間隔組為86.2%,長(zhǎng)間隔組為83.1%,無(wú)統(tǒng)...
【文章來(lái)源】:重慶醫(yī)科大學(xué)重慶市
【文章頁(yè)數(shù)】:40 頁(yè)
【學(xué)位級(jí)別】:碩士
【部分圖文】:
比較兩組間無(wú)病生存期的Kaplan-Meier曲線
圖1 比較兩組間無(wú)病生存期的Kaplan-Meier曲線直腸癌新輔助放化療后行標(biāo)準(zhǔn)的TME手術(shù)的間隔時(shí)間仍然存在較大的爭(zhēng)議。多數(shù)研究認(rèn)為適當(dāng)延長(zhǎng)手術(shù)時(shí)間間隔能夠更好減少局部復(fù)發(fā)率,但延長(zhǎng)具體時(shí)間仍沒(méi)有確定。本研究將時(shí)間間隔延長(zhǎng)至70天,分析了手術(shù)情況、術(shù)后并發(fā)癥、病理檢查結(jié)果及腫瘤學(xué)結(jié)局。
【參考文獻(xiàn)】:
期刊論文
[1]直腸癌新輔助治療后等待觀察策略專家共識(shí)(2020版)[J]. ChineseWatch&WaitDatabaseResearchCooperationGroup(CWWD);ChineseAssociationofSurgeons,ChineseSocietyofColoproctology,ChineseMedicalDoctorAssociation;ChineseSocietyofColorectalSurgery,ChineseMedicalAssociation;ColorectalCancerPhysicianSpecialtyCommittee,ChineseMedicalDoctorAssociation;RadiationTherapySpecialtyCommittee,ChineseAnticancerAssociation. 中華胃腸外科雜志. 2020(01)
[2]Long-term outcomes in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy and curative resection[J]. Zhao Lu,Pu Cheng,Fu Yang,Zhaoxu Zheng,Xishan Wang. Chinese Journal of Cancer Research. 2018(02)
[3]AJCC-TRG聯(lián)合ypTN分期評(píng)價(jià)局部進(jìn)展期直腸癌預(yù)后[J]. 魏嘉旺,肖巍魏,奚少?gòu)?常暉,王俏鏇,李力人,張惠忠,曾智帆,丁培榮,高遠(yuǎn)紅. 中華放射腫瘤學(xué)雜志. 2017 (10)
[4]Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer[J]. Mehmet Mihmanl?,Esin Kabul Gürbulak,?smail Ethem Akgün,Mustafa Fevzi Celayir,P?nar Yaz?c?,Deniz Tun?el,Tuba Tülin Bek,Ayhan ?z,Sinan ?mero?lu. World Journal of Gastrointestinal Oncology. 2016(09)
本文編號(hào):3374967
【文章來(lái)源】:重慶醫(yī)科大學(xué)重慶市
【文章頁(yè)數(shù)】:40 頁(yè)
【學(xué)位級(jí)別】:碩士
【部分圖文】:
比較兩組間無(wú)病生存期的Kaplan-Meier曲線
圖1 比較兩組間無(wú)病生存期的Kaplan-Meier曲線直腸癌新輔助放化療后行標(biāo)準(zhǔn)的TME手術(shù)的間隔時(shí)間仍然存在較大的爭(zhēng)議。多數(shù)研究認(rèn)為適當(dāng)延長(zhǎng)手術(shù)時(shí)間間隔能夠更好減少局部復(fù)發(fā)率,但延長(zhǎng)具體時(shí)間仍沒(méi)有確定。本研究將時(shí)間間隔延長(zhǎng)至70天,分析了手術(shù)情況、術(shù)后并發(fā)癥、病理檢查結(jié)果及腫瘤學(xué)結(jié)局。
【參考文獻(xiàn)】:
期刊論文
[1]直腸癌新輔助治療后等待觀察策略專家共識(shí)(2020版)[J]. ChineseWatch&WaitDatabaseResearchCooperationGroup(CWWD);ChineseAssociationofSurgeons,ChineseSocietyofColoproctology,ChineseMedicalDoctorAssociation;ChineseSocietyofColorectalSurgery,ChineseMedicalAssociation;ColorectalCancerPhysicianSpecialtyCommittee,ChineseMedicalDoctorAssociation;RadiationTherapySpecialtyCommittee,ChineseAnticancerAssociation. 中華胃腸外科雜志. 2020(01)
[2]Long-term outcomes in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy and curative resection[J]. Zhao Lu,Pu Cheng,Fu Yang,Zhaoxu Zheng,Xishan Wang. Chinese Journal of Cancer Research. 2018(02)
[3]AJCC-TRG聯(lián)合ypTN分期評(píng)價(jià)局部進(jìn)展期直腸癌預(yù)后[J]. 魏嘉旺,肖巍魏,奚少?gòu)?常暉,王俏鏇,李力人,張惠忠,曾智帆,丁培榮,高遠(yuǎn)紅. 中華放射腫瘤學(xué)雜志. 2017 (10)
[4]Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer[J]. Mehmet Mihmanl?,Esin Kabul Gürbulak,?smail Ethem Akgün,Mustafa Fevzi Celayir,P?nar Yaz?c?,Deniz Tun?el,Tuba Tülin Bek,Ayhan ?z,Sinan ?mero?lu. World Journal of Gastrointestinal Oncology. 2016(09)
本文編號(hào):3374967
本文鏈接:http://sikaile.net/shoufeilunwen/mpalunwen/3374967.html
最近更新
教材專著